SUNSHINE BIOPHARMA INC. (SBFMW) Operating margin 2019–2025
SUNSHINE BIOPHARMA INC. (SBFMW) operating margin by fiscal year — reported operating income divided by reported revenue.
-17.2%FY2025 · since FY2019: -3037.9% → -17.2%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -17.2% | -0.5 pp |
| FY2024 | -16.7% | +3.2 pp |
| FY2023 | -19.9% | +601.5 pp |
| FY2022 | -621.3% | +446.9 pp |
| FY2021 | -1068.2% | -260.4 pp |
| FY2020 | -807.8% | +2230.1 pp |
| FY2019 | -3037.9% | — |
Operating margin = reported operating income ÷ reported revenue for the same fiscal year. Operating-loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice